Outcomes after early or midfollicular phase LH supplementation in previous inadequate responders

Reproductive BioMedicine Online

Volumn 20, Issue 3, 2010, Pages 350-357

  Sonmezer M ^a   Duvan, C Ltemir ^b   Ozmen B ^a   Tai, T ^a   Ozkavuku S ^a   Atabekolu, C S ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b FATIH UNIVERSITY   (Turkey)

Author keywords

HMG; ICSI; Luteal GnRH agonist protocol; RFSH; Suboptimal ovarian response

Indexed keywords

GONADORELIN DERIVATIVE; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FERTILIZATION; FOLLICULAR PHASE; HORMONAL THERAPY; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; METAPHASE; OVARIAN STIMULATION; OVARY FUNCTION; PREGNANCY RATE; RETROSPECTIVE STUDY; SUPPLEMENTATION;

ADULT; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMANS; LUTEINIZING HORMONE; MENOTROPINS; OVULATION INDUCTION; PREGNANCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78649321908     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2009.11.022     Document Type: Article

References (33)

1. Asian Puregon Study Group E.H.M. Hoomans, and B.B. Mulder A group-comparative, randomized, double-blind comparison of the efficacy and efficiency of two fixed daily dose regimens (100- and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon®) in Asian women undergoing ovarian stimulation for IVF/ICSI J. Assist. Reprod. Genet. 19 2002 470 476
2. J. Balasch, E. Vidal, and J. Peñarrubia Suppression of LH during ovarian stimulation, analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH Hum. Reprod. 16 2001 1636 1643
3. G. Barrenetxea, J.A. Agirregoikoa, and M.R. Jiménez Ovarian response and pregnancy outcome in poor-responder women, a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles Fertil. Steril. 89 2008 546 553
4. S. Costagliola, P. Niccoli, and M. Florentino European collaborative study on luteinizing hormone assay, 2. Discrepancy among assay kits is related to variation both in standard curve calibration and epitope specificity of kit monoclonal antibodies J. Endocrinol. Invest. 17 1994 407 416
5. G. De Placido, C. Alviggi, and A. Mollo Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation Clin. Endocrinol. (Oxf.) 60 2004 637 643
6. G. De Placido, C. Alviggi, and A. Perino Italian Collaborative Group on Recombinant Human Luteinizing Hormone. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial Hum. Reprod. 20 2005 390 396
7. G. De Placido, A. Mollo, and C. Alviggi Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH Hum. Reprod. 16 2001 1875 1879
8. M.A. Esposito, K.T. Barnhart, and C. Coutifaris Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone Fertil. Steril. 75 2001 519 524
9. B. Ferrari, L. Barusi, and F. Coppola Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study J. Reprod. Med. 47 2002 137 143
10. H.L. Fevold Synergism of follicle stimulating and luteinizing hormones in producing estrogen secretion Endocrinology 28 1941 33 36
11. M. Filicori, G.E. Cognigni, and S. Taraborrelli Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome J. Clin. Endocrinol. Metab. 84 1999 2659 2663
12. R. Fleming, F. Lloyd, and M. Herbert Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone Hum. Reprod. 13 1998 1788 1792
13. R.O. Greep, H.B. Van Dyke, and B.F. Chow Gonadotropin of swine pituitary, various biological effects of FSH and ICSI Endocrinology 30 1942 635 649
14. S.G. Hillier Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis Human Reproduction 9 1994 188 191
15. I. Huhtaniemi, M. Jiang, and C. Nilsson Mutations and polymorphisms in gonadotropin genes Mol. Cell. Endocrinol. 151 1999 89 94
16. P. Humaidan To add or not to add LH, comments on a recent commentary Reprod. Biomed. Online 12 2006 284 285
17. P. Humaidan, L. Bungum, and M. Bungum Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation Hum. Reprod. 17 2002 2016 2021
18. P. Humaidan, M. Bungum, and L. Bungum Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH, an opening study Reprod. Biomed. Online 8 2004 635 643
19. M. Jiang, P. Pakarinen, and F.P. Zhang A common polymorphic allele of the human luteinizing hormone beta-subunit gene, additional mutations and differential function of the promoter sequence Hum. Mol. Genet. 8 1999 2037 2046
20. T. Laml, A. Obruca, and F. Fischl Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women Gynecol. Endocrinol. 13 1999 98 103
21. F. Lisi, L. Rinaldi, and S. Fishel Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF, a preliminary study Reprod. Biomed. Online 3 2001 190 194
22. R. Marrs, D. Meldrum, and S. Muasher Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment Reprod. Biomed. Online 8 2004 175 182
23. K.P. McNatty, W.M. Hunter, and A.S. MacNeilly Changes in the concentration of pituitary and steroid hormones in the follicular fluid of human graafian follicles throughout the menstrual cycle J. Endocrinol. 64 1975 555 571
24. P. Niccoli, S. Costagliola, and M.C. Patricot European collaborative study of LH assay, 3. relationship of immunological reactivity, biological activity and charge of human luteinizing hormone J. Endocrinol. Invest. 19 1996 260 267
25. A. Nyboeandersen, P. Humaidan, and G. Fried Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial Hum. Reprod. 23 2008 427 434
26. J.B. Oliveira, A.L. Mauri, and C.G. Petersen Recombinant luteinizing hormone supplementation to recombinant follicle-stimulation hormone during induced ovarian stimulation in the GnRHagonist protocol, a meta-analysis J. Assist. Reprod. Genet. 24 2007 67 75
27. J.H. Out, I. David, and R. Ron-El A randomized, double-blind clinical trial using fixed dialy doses of 100 or 200 IU of recombinant FSH in ICSI cyles Hum. Reprod. 16 2001 1104 1109
28. J.H. Out, S. Lindenberg, and A.N. Mikkelsen A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon®) in women undergoing ovarian stimulation Hum. Reprod. 14 1999 622 627
29. J. Peñarrubia, F. Fábregues, and M. Creus LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH Hum. Reprod. 18 2003 2689 2697
30. M.G. Ropelato, M.C. Garcia-Rudaz, and C. Castro-Fernandez A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome J. Clin. Endocrinol. Metab. 84 1999 4629 4636
31. Z. Shoham The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation Fertil. Steril. 77 2002 1170 1177
32. The European Recombinant Human LH Study Group Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women, a dose-finding study J. Clin. Endocrinol. Metab. 83 1998 1507 1514
33. L.G. Westergaard, S.B. Laursen, and C.Y. Andersen Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction Hum. Reprod. 15 2000 1003 1008